BIOMAT Database Logo BIOMAT Database Logo

Long-term treatment of infantile nephropathic cystinosis with cysteamine. 1985

V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003543 Cysteamine A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS. Cysteinamine,Mercaptamine,2-Aminoethanethiol,Becaptan,Cystagon,Cysteamine Bitartrate,Cysteamine Dihydrochloride,Cysteamine Hydrobromide,Cysteamine Hydrochloride,Cysteamine Maleate (1:1),Cysteamine Tartrate,Cysteamine Tartrate (1:1),Cysteamine Tosylate,Cysteamine, 35S-Labeled,Mercamine,Mercaptoethylamine,beta-Mercaptoethylamine,2 Aminoethanethiol,35S-Labeled Cysteamine,Bitartrate, Cysteamine,Cysteamine, 35S Labeled,Dihydrochloride, Cysteamine,Hydrobromide, Cysteamine,Hydrochloride, Cysteamine,Tartrate, Cysteamine,Tosylate, Cysteamine,beta Mercaptoethylamine
D003553 Cystine A covalently linked dimeric nonessential amino acid formed by the oxidation of CYSTEINE. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Copper Cystinate,L-Cystine,L Cystine

Related Publications

V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Treatment of infantile nephropathic cystinosis with cysteamine.
May 1986, The New England journal of medicine,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Nephropathic cystinosis: effect of long-term cysteamine therapy.
June 1987, Clinical nephrology,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Cysteamine treatment of nephropathic cystinosis.
January 1983, Progress in clinical and biological research,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Pharmacological treatment of nephropathic cystinosis with cysteamine.
November 2004, Expert opinion on pharmacotherapy,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Cholestatic liver disease in long-term infantile nephropathic cystinosis.
August 2008, Journal of gastroenterology and hepatology,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Infantile nephropathic cystinosis.
March 2008, Kidney international,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Infantile nephropathic cystinosis.
January 2011, Srpski arhiv za celokupno lekarstvo,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Cysteamine therapy in nephropathic cystinosis.
May 1981, The New England journal of medicine,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
May 2005, Medicine,
V A da Silva, and R P Zurbrügg, and P Lavanchy, and A Blumberg, and H Suter, and S R Wyss, and C M Lüthy, and O H Oetliker
Cysteamine therapy for children with nephropathic cystinosis.
April 1987, The New England journal of medicine,
Copied contents to your clipboard!